Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T Cells
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiae166 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Nienke H van Teijlingen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Prevotella, Dysbiosis, Vagina, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council, European Research Council.
Abstract (Originalsprache)
Dysbiosis of the vaginal microbiome poses a serious risk for sexual human immunodeficiency virus type 1 (HIV-1) transmission. Prevotella spp are abundant during vaginal dysbiosis and associated with enhanced HIV-1 susceptibility; however, underlying mechanisms remain unclear. Here, we investigated the direct effect of vaginal bacteria on HIV-1 susceptibility of vaginal CD4+ T cells. Notably, pre-exposure to Prevotella timonensis enhanced HIV-1 uptake by vaginal T cells, leading to increased viral fusion and enhanced virus production. Pre-exposure to antiretroviral inhibitors abolished P timonensis–enhanced infection. Our study shows that the vaginal microbiome directly affects mucosal CD4+ T-cell susceptibility, emphasizing importance of vaginal dysbiosis diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.
- Department of Obstetrics and Gynecology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
- Advanced Therapy Medicinal Product Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic center for Education, Culture and Research, Tehran, Iran.
- Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
- Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Nienke H van Teijlingen, Marleen Y van Smoorenburg, Ramin Sarrami-Forooshani, John L van Hamme, Hanneke Borgdorff, Janneke H H M van de Wijgert, Elisabeth van Leeuwen, Joris A M van der Post, Karin Strijbis, Carla M S Ribeiro, Teunis B H Geijtenbeek
Förderung
- Dutch Research Council
- European Research Council
Zitieren
APA
van Teijlingen, N. H., van Smoorenburg, M. Y., Sarrami-Forooshani, R., Zijlstra-Willems, E. M., van Hamme, J. L., Borgdorff, H., van de Wijgert, J. H. H. M., van Leeuwen, E., van der Post, J. A. M., Strijbis, K., Ribeiro, C. M. S., & Geijtenbeek, T. B. H. (2024). Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T Cells. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae166
Vancouver
van Teijlingen NH, van Smoorenburg MY, Sarrami-Forooshani R, Zijlstra-Willems EM, van Hamme JL, Borgdorff H, et al. Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T Cells. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae166
BibTeX
@article{vanTeijlingen2024,
author = {van Teijlingen, Nienke H and van Smoorenburg, Marleen Y and Sarrami-Forooshani, Ramin and Zijlstra-Willems, Esther M and van Hamme, John L and Borgdorff, Hanneke and van de Wijgert, Janneke H H M and van Leeuwen, Elisabeth and van der Post, Joris A M and Strijbis, Karin and Ribeiro, Carla M S and Geijtenbeek, Teunis B H},
title = {Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T Cells},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiae166}
}
EUVIMED